Intravenous thrombolysis pretreatment and other predictors of infarct in a new previously unaffected territory (INT) in ELVO strokes treated with mechanical thrombectomy.


Journal

Journal of neurointerventional surgery
ISSN: 1759-8486
Titre abrégé: J Neurointerv Surg
Pays: England
ID NLM: 101517079

Informations de publication

Date de publication:
Feb 2020
Historique:
received: 18 03 2019
revised: 04 06 2019
accepted: 05 06 2019
pubmed: 28 6 2019
medline: 2 6 2020
entrez: 28 6 2019
Statut: ppublish

Résumé

One uncommon complication of mechanical thrombectomy (MT) is an infarct in a new previously unaffected territory (infarct in new territory (INT)). To evaluate the predictors of INT with special focus on intravenous thrombolysis(IVT)pretreatmentbefore MT. Consecutive patients with emergent large vessel occlusion (ELVO) treated with MT during a 5-year period were evaluated. INT was defined using standardized methodology proposed by ESCAPE investigators. The predictors of INT and its impact on outcomes were investigated. A total of 419 consecutive patients with ELVO received MT (mean age 64±15 years, 50% men, median baseline National Institutes of Health Stroke Scale score 16 points (IQR 11-20), 69% pretreated with IVT). The incidence of INT was lower in patients treated with combination therapy (IVTandMT) than in patients treated with MT alone, respectively (10% vs 20%; p=0.011). The INT group had more patients with posterior circulation occlusions than the group without INT (28% vs 10%, respectively; p<0.001). The rates of 3-month functional independence were lower in patients with INT (30% vs 50%; p=0.007). IVT pretreatment was not independently related to INT (OR=0.75; 95% CI 0.32 to 1.76), and INT did not emerge as an independent predictor of 3-month functional independence (OR=0.69; 95% CI 0.29 to 1.62) on multivariable logistic regression models. Location of posterior circulation occlusion was independently associated with a higher odds of INT (OR=3.33; 95% CI 1.43 to 7.69; p=0.005). IVT pretreatment is not independently associated with a lower likelihood of INT in patients with ELVO treated with MT. Patients with ELVO with posterior circulation occlusion are more likely to have INT after MT.

Identifiants

pubmed: 31243068
pii: neurintsurg-2019-014935
doi: 10.1136/neurintsurg-2019-014935
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

142-147

Informations de copyright

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Nitin Goyal (N)

Neurology, University of Tennessee Health Science Center, Memphis, Tennessee, USA.

Georgios Tsivgoulis (G)

Second Department of Neurology, "Attikon" Hospital, School of Medicine, University of Athens, Athens, Greece.

Jason J Chang (JJ)

Critical Care, MedStar Washington Hospital Center, Washington, District of Columbia, USA.

Konark Malhotra (K)

West Virginia University Health Sciences Center Charleston Division, Charleston, West Virginia, USA.

Juan Goyanes (J)

Neurology, University of Tennessee Health Science Center, Memphis, Tennessee, USA.

Abhi Pandhi (A)

Neurology, University of Tennessee Health Science Center, Memphis, Tennessee, USA.

Rashi Krishnan (R)

Neurology, University of Tennessee Health Science Center, College of Medicine Memphis, Memphis, Tennessee, USA.

Muhammad F Ishfaq (MF)

Neurology, University of Tennessee Health Science Center, Memphis, Tennessee, USA.

Daniel Hoit (D)

Neurosurgery, University of Tennessee, Memphis, Tennessee, USA.

Christopher Nickele (C)

UTHSC, Department of Neurosurgery, Memphis, Tennessee, USA.

Violiza Inoa-Acosta (V)

Semmes-Murphey Neurologic and Spine Institute, Memphis, Tennessee, USA.

Aristeidis H Katsanos (AH)

Department of Neurology, University of Ioannina School of Medicine, Ioannina, Greece.

Lucas Elijovich (L)

Semmes-Murphey Clinic, Memphis, Tennessee, USA.

Andrei Alexandrov (A)

Surgery, University of Alabama, Birmingham, Alabama, Alabama, USA.

Adam S Arthur (AS)

UT Department of Neurosurgery/Semmes-Murphey Clinic, Memphis, Tennessee, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH